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Non-communicable diseases (NCDs) have been recognised as a major 
cause of disability and death[1-5] for three decades. The 2010 Global 
Burden of Disease Study[1] estimated that NCD deaths increased 
from about 8 million in 1990 to 52.8 million in 2010, or 65% of all 
deaths in that year. A high proportion of the burden occurs in low- 
and middle-income countries.[1-7] In 2005, Strong et al.[8] suggested a 
target of reducing chronic disease mortality by 2% per annum, and 
the high-level United Nations summit on NCDs in September 2011 
heralded a global commitment to address the growing burden.[9,10] 
Countries agreed to adopt nine global targets,[11] including the ‘25 × 25’ 
overarching target of reducing premature mortality from the four main 
NCDs (cardiovascular diseases (CVDs, including cerebrovascular 
disease), chronic respiratory diseases, cancers and diabetes mellitus) by 
25% compared with their 2010 levels by 2025.
The decline in NCD mortality rates observed in most high-
income countries since the 1960s[12-14] has been attributed to 
decreases in population levels of major risk factors including 
smoking, unhealthy diet, physical inactivity and alcohol use,[3,13,15,16] 
as well as improved treatment.[12,15] There are limited data on trends 
in mortality rates in low- and middle-income countries,[10] although 
it is predicted that NCDs will continue to rise in these countries 
owing to population ageing and lifestyle changes associated with 
socioeconomic development and urbanisation.[3,12,16-18]
The initial South African (SA) National Burden of Disease Study 
estimated that in 2000 NCDs accounted for 41% of all deaths.[19] 
SA has relatively high levels of risk factors for NCDs.[20] With the 
exception of reductions in tobacco smoking from 34% in 1995,[21] 
prior to the anti-tobacco legislation, to 24% in 2009, other NCD 
risk factors have increased with distinct gender patterns. In 2008, 
43% of men and 41% of women had raised blood pressure,[22] 46% 
of men and 56% of women were physically inactive,[22] and the 
prevalence of overweight and obesity was 58.5% for men and 71.8% 
for women. [22,23] The prevalence of raised blood cholesterol was 31% 
for men and 37% for women, and 5.9% of men and 2.0% of women[24] 
reported risky alcohol use.
The second National Burden of Disease Study for SA is focusing 
on trends in deaths and premature mortality from 140 causes of 
death.[25] In this article we report on deaths from NCDs and examine 
trends in age-standardised death rates (ASDRs) between 1997 and 
2010 nationally and by population group from 2000 onwards.
Methods
Death data obtained from Statistics South Africa for 1997 - 2010 
were used for the analysis of NCD mortality.[26] The analysis steps 
are detailed elsewhere.[25] Briefly, data integrity was assessed using 
data cleaning processes and validity, and adjustments were made for 
underreporting. Causes of death were grouped according to the SA 
National Burden of Disease list, comprising four broad cause groups: 
HIV/AIDS and tuberculosis; other communicable diseases, plus 
maternal, perinatal and nutritional conditions; non-communicable 
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diseases; and injuries, with 24 disease 
categories and 140 single causes.[25] In this 
article stroke is used interchangeably with 
cerebrovascular disease, renal disease with 
nephritis and nephrosis, and cancers with 
malignant neoplasms.
For selected underlying causes of death 
(UCODs), the data were recoded to add ress 
identified inconsistencies based on epi-
demiological and clinical expertise within 
the team. These included the selec tion of 
diabetes mellitus or epilepsy as the UCOD 
for cases based on the multiple-competing 
UCOD reported in part 1 of the death 
notification form.[27] Cases with diabetes 
mellitus as the UCOD that had a competing 
cause reported in part 1 were recoded to: (i) 
stroke (I60-I69) if stroke was also reported 
in part 1; (ii) ischaemic heart disease 
(IHD) (I20-I25) if this was also reported 
in part 1; (iii) hypertensive heart disease 
(I11) if this was also reported in part 1; 
and (iv) nephritis and nephrosis (N00-
N08, N10-N12, N17-N19) if hypertensive 
renal disease (I12) was also reported in 
part 1. Cases in which epilepsy (G40-G41) 
was reported as the UCOD with stroke 
(I60-I69) as the competing cause were 
recoded to stroke (I60-I69). Cases with 
hypertension (I10) reported with no other 
UCOD were redistributed proportionally 
by age and sex to hypertensive heart 
disease (I11), hypertensive renal disease 
(I12), hypertensive renal and heart disease 
(I13), renal disease (N00-N08, N10-N12, 
N17-N19), IHD (I20-I25), cerebrovascular 
disease (I60-I69, G81) and aortic aneurysm 
(I71), while those with other causes reported 
were recoded to general ill-defined. Cases 
with hypertensive renal disease (I12) as 
the UCOD were combined with other 
nephritis and nephrosis (N00-N08, N10-
N12, N17-N19), while hypertensive heart 
and renal disease (I13) were combined with 
hypertensive heart disease (I11).
Deaths with unknown age, sex and 
population group were redistributed pro-
portionally,[25] misclassified HIV/AIDS 
deaths were identified from 18 conditions 
(none NCDs) based on a regression 
approach, and underspecified and ill-
defined conditions were redistributed 
according to the strategies developed by 
the team in consultation with experts.[28] 
Years of life lost (YLLs) were calculated 
using 3% per annum discounting[29] and 
the level 26 West model life-table[30,31] for 
standard expectations by age. ASDRs 
were calcu lated using alternative mid-
year esti mates[32] and the World Health 
Organization world standard.[33] Pre-
mature mortality from CVDs, cancers, 
respiratory disease and diabetes mellitus 
was calculated as the risk of death (40q30) 
from these causes between the ages of 30 
and 70 years based on the quinquennial 
death rates (5mx), such that:
National trends in deaths and ASDRs are 
reported by broad cause groups, categories 
of conditions and single causes. Population 
group according to previously defined 
apartheid categories of black African, 
coloured, Indian/Asian, white and other was 
introduced into the new death notification 
in 1998[34] to track health inequalities. Since 
population group was reported for about 
75% of deaths since 2000, it was possible 
to estimate trends by population group for 
2000 - 2010.
Results
NCD mortality
Of the estimated 594 071 deaths in 2010, 
38.9% were due to NCDs (42.6% of 
females and 35.4% of males). A sizeable 
proportion (14.7%) of those who died 
were aged <45 years and 21.5% were aged 
45 - 59 years, indicating a considerable 
number of premature deaths. Premature 
mortality (30 - 70 years) for CVDs, cancer, 
respiratory conditions and diabetes melli-
tus remained level at about 29.0% until 
2004, but by 2010 had declined to 26.0%. 
Based on YLLs, NCDs accounted for 
27.8% of the premature burden (30.1% 
of female YLLs and 25.7% of male YLLs) 
in 2010. The ASDR for NCDs was level at 
about 669/100 000 population from 1997, 
then increased in 2003 to 710/100  000 
population before declining again to 
634/100 000 popu lation in 2010. A drop 
from 817/100 000 population (in 2003) to 
747/100 000 (2010) for males, and from 
631/100 000 population to 560/100 000 for 
females, was observed. In addition to the 
differences by sex, Fig. 1 shows differen-
tials by population group. The ASDRs for 
white South Africans were substantially 
lower than other groups. Small declines 
were observed for black Africans and 
whites, with more marked declines for 
Asians and coloureds since 2000.
Despite decreasing rates, Fig. 2 shows the 
increasing number of deaths from NCDs 
since 1997, reaching just over 230 000 by 
2010. The decomposition of the change 
between 1997 and 2010 (Table 1) indicates 
that the increase is due to population growth 
and a change in age structure, particularly 
for females.
The cause composition of NCD deaths 
changed very slightly, and by 2010, 44.0% of 
NCD deaths were due to CVDs, 18.0% to 
cancers, 9.3% to chronic respiratory diseases 
and 8.0% to diabetes mellitus. For that year, 
the leading single cause of NCD deaths was 
stroke, followed by IHD, hypertensive heart 
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Fig. 1. ASDRs from NCDs for males (A) and females (B) by population group, SA 2000 - 2010.
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Fig. 2. Number of deaths from NCDs, SA 1997 - 2010.
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disease and diabetes mellitus (Table 2). For 
females, cervical and breast cancers ranked 
in the top 10 causes of death, while lung and 
prostate cancers were reported for males. 
Substantial increases in ASDRs were observed 
for diabetes mellitus, renal disease, prostate 
and breast cancer, and endocrine, nutritional, 
blood and immune disorders, while decreases 
occurred for chronic obstructive pulmonary 
disease (COPD), asthma and lung cancer. 
From Table 2 it can also be seen that the 
overall decline in ASDRs from NCDs was 
5% over the 14-year period, or 0.4% per year, 
much lower than the recommended goal of 
2% per year.
CVDs, diabetes mellitus and  
renal disease
Cerebrovascular disease, the leading CVD 
cause of death, has been the leading cause 
of NCD deaths over the period. In 2010 it 
became the second leading cause of total 
deaths following HIV/AIDS (accounting 
for 5.1% of total male deaths and 8.6% of 
total female deaths). Stroke mortality rates 
were similar for males and females and 
increased to about 133/100 000, followed 
by a decline to about 114/100 000 in 2010 
(Fig. 3). In contrast, IHD mortality rates 
dec lined slightly and male rates were about 
1.8 times higher than rates for females in 
2010. Hypertensive heart disease and cardio-
myopathy showed little change over the 
period. While hypertensive heart disease was 
slightly higher for females than males, death 
rates from cardiomyopathy were 1.3 times 
higher for males. Death rates from diabetes 
mellitus and renal disease increased steadily. 
While death rates for diabetes mellitus were 
similar for males and females, renal disease 
death rates were higher for males than 
females.
ASDRs for CVDs and diabetes mellitus 
by gender and population group for the 
years 2000 - 2010 are shown in Fig. 4. 
Marked declines in CVDs and diabetes 
mellitus were noted among coloureds and 
Asians, while there was an increase among 
black Africans.
Table 1. Decomposition of change in NCDs into population growth, change in rate 
and change in age
Male Female Total
1997 deaths 99 520 97 318 196 838
 Deaths expected with 2010 population, 1997 population 
age structure, 1997 death rates, n
115 616 112 980 228 593
 Deaths expected with 2010 population, 2010 population 
age structure, 1997 death rates, n
119 077 128 163 247 240
2010 deaths 108 405 122 724 231 129
Change from 1997 due to population growth, % 16.2 16.1 16.1
Change from 1997 due to change in age structure, % 3.5 15.6 9.5
Change from 1997 due to change in death rates, % –10.7 –5.6 –8.2
Change from 1997 to 2010, % 8.9 26.1 17.4
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Fig. 3. ASDRs for CVDs, diabetes mellitus and renal disease for males (A) and females (B), SA 1997 - 2010.
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Population groups in different stages of the cardiovascular transi-
tion[35,36] are shown in Fig. 5. While Asians have distinctively 
high rates of IHD and renal disease, black Africans are in the 
midst of a CVD epidemic with relatively high mortality rates from 
cardiomyopathy, hypertensive heart disease, stroke and diabetes 
mellitus, and can be expected to transition towards IHD as living 
conditions and behaviours change.
Cancers and chronic respiratory diseases
Fig. 6 shows ASDRs from more common cancers. Cancer death 
rates for females were generally lower than for males, but the lack 
of national cancer incidence data makes it impossible to confirm 
the findings.[37] There was a marked decline for oesophageal and 
lung cancer for males, while prostate cancer increased. For females 
oeso phageal cancer decreased, with little change in lung cancer and 
a slight increase in breast cancer. In contrast, oesophageal cancer 
inci dence rates for both sexes in rural populations have remained 
high. [38,39] Kaposi’s sarcoma deaths have not been reported, as they 
were reallocated to HIV/AIDS because of the strong association of this 
tumour with AIDS. While there has been an increase in the number of 
deaths due to Kaposi’s sarcoma, it ranked 9th and 10th among cancers 
for males and females, respectively, in the raw data in recent years.
The overall mortality rate from cancers in 2010 was 114/100 000 
(using the International Agency for Research on Cancer standard 
population as denominator, the rate was 100/100 000). However, 
cancer death rates differed by population group. In 2010, the cancer 
death rate for coloureds was 1.8 times higher than that for black 
Africans (Fig. 7), arising from high lung and prostate cancer rates 
for coloureds (Fig. 8, B and D) and low rates for black Africans for 
most cancers apart from oesophageal and cervical cancer (Fig. 7). 
There was a marked population group difference in cancers of the 
alimentary canal (Fig. 8, C).
Fig. 9 shows trends in death rates from chronic respiratory 
diseases. Males had a high mortality from COPD (about 60/100 000 
population) during the early period, dropping to 48/100 000 
population in 2010. The rates were more than double those for 
females. In contrast, asthma mortality was only slightly higher for 
males and also declined. Fig. 10 shows that both level of mortality and 
the gender difference were lowest in whites.
Discussion
Over the past 14 years, NCDs have continued to be a major cause 
of mortality in SA, despite the country’s profound AIDS epidemic. 
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NCDs accounted for 39% of deaths in 2010 and for considerable 
premature mortality. CVDs were the major NCDs, and by 2010 stroke 
had become the second leading cause of death after HIV/AIDS. Of 
the approximately 230 000 South Africans who died from NCDs in 
2010, 36% had not reached the average life expectancy of 60 years. 
This study shows that there has been a steady increase in deaths due 
to NCDs, driven by population growth and a shift in the age structure 
towards older ages. However, ASDRs for NCDs declined by 0.4% per 
annum over this period, short of the recommended 2%.
The importance of tracking cause-specific trends has been revealed, 
and the study shows decreasing stroke mortality from 2003 onwards, 
as well as declines in IHD, lung and oesophageal cancer, COPD 
and asthma. The early introduction of tobacco control strategies 
has probably contributed to these declines, along with other factors. 
The drop in oesophageal cancer mortality may also be related to 
urbanisation and dietary changes including shifts from consuming 
home-grown to commercial maize.[40] In contrast, mortality from 
diabetes mellitus, renal disease and endocrine/nutritional and blood 
immune disorders has increased. This is in keeping with the increase in 
overweight and obesity observed in national surveys,[41,42] urbanisation, 
and the observation that diabetes mellitus has increased rapidly in all 
age groups in urban settings.[43] Addressing the increase in obesity is a 
global challenge, and in the past 30 years, no country has been able to 
buck the trend.[44] Gortmarker et al.[45] have identified priority actions 
that focus on policies to improve nutrition and built environments, 
cross-cutting actions (such as leadership, healthy public policies, and 
monitoring), and greater investment in prevention.
Some of these findings can be attributed to a strong gender 
tend ency towards women being overweight and obese, and men 
smoking and drinking.[22,23] Differences among population groups 
are likely to be driven by socioeconomic differentials. These 
in equalities are replicated in access to healthcare, screening, 
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diagnosis and treatment. [46] Many disadvantaged people remain 
undiagnosed, untreated and at risk of preventable complications. 
Lack of health insurance results in disadvantaged people suffering 
higher rates of ill-health than other groups.[47] The higher mortality 
rates from cardiomyopathy among black Africans compared with 
other groups may be attributable to underlying low socioeconomic 
status,[47,48] environmental factors and historical issues (such 
as forced displacement, extreme poverty, and limited access 
to healthcare and education, employment and social services). 
Findings from Sliwa et al.[49] and other studies on black Africans 
have established that patients affected by advanced HIV/AIDS 
tend to develop cardiomyopathies.[50,51] Alcoholism, poor nutrition 
and low socioeconomic status have also been cited as factors 
contributing to cardiomyopathy.
Adopting global recommendations, SA launched a Strategic Plan 
for the Prevention of Non-communicable Diseases 2013-17 in 
September 2013. This provides an overarching framework for chronic 
disease prevention by promoting health and wellness at community 
and individual levels and strengthening primary healthcare. Building 
on the comprehensive tobacco control legislation, which appears to 
be responsible for much of the decline in NCDs, the Strategic Plan 
has identified key population-wide interventions to prevent and 
control NCDs through legislation and regulation. Salt use regulations 
and other nutritional policies are currently being implemented and 
should increase the momentum for prevention and control of NCDs. 
On the other hand, alcohol policy development has been slow. The 
substantive increases observed in mortality rates from prostate and 
breast cancers point to the need for more public awareness about 
cancers and the need for early detection and treatment services to 
be available.
Reliable and robust surveillance is integral to disease control and 
essential for planning and implementing health policy.[1] The 
Strategic Plan includes time-bound targets, including the reduction 
of premature mortality. Improved surveillance is needed to support 
the Plan and should include improvements in vital registration[52] and 
population-based surveys to monitor risk factors, their determinants 
and key intervention coverage.[53] In addition, to monitor primary care 
programmes,[18] cohort data on chronic disease patients are essen tial. 
The use of a standardised clinical summary sheet in patient folders 
would enable audits[54] based on record reviews as an interim measure. 
This should be accompanied by a patient-held card, tracking progress 
on risk factors, which could help to motivate individuals to change 
health-related behaviours.
Study limitations
Several limitations of this study must be acknowledged. Firstly, 
although there have been considerable improvements, the quality 
of death certification is still inadequate with a relatively high 
proportion of ill-defined and misattributed causes. Misclassification 
of cardiovascular and diabetes causes has been observed, and although 
adjustments were made based on multiple-cause information, it is 
possible that a degree of error remains in our estimates. Secondly, 
despite regular census data being available, there is uncertainty 
in population estimates, which adds to uncertainty in estimated 
mortality rates. Thirdly, for the population group differences 
information was missing for about a quarter of the deaths and 
needed to be imputed. Nonetheless, face validity of the trends and 
differentials indicates that these estimates are robust, and SA clearly 
needs to take further steps to reach the recommended goal of a 2% 
reduction per annum.[8] Tracking the emerging trends in the death 
rates is an essential tool to assist with monitoring and modifying the 
Strategic Plan.
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